UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?

Hughes, G; Bern, H; Chiang, CY; Goodall, RL; Nunn, AJ; Rusen, ID; Meredith, SK; (2022) ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation? The International Journal of Tuberculosis and Lung Disease , 26 (11) pp. 1065-1070. 10.5588/ijtld.22.0063. Green open access

[thumbnail of Hughes_2nd STREAM 1 QT prolongation paper_IJTLD format_R1.pdf]
Preview
Text
Hughes_2nd STREAM 1 QT prolongation paper_IJTLD format_R1.pdf - Accepted Version

Download (430kB) | Preview

Abstract

BACKGROUND: STREAM (Standardised Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) Stage 1 was a randomised trial of a Short (9-month) regimen for rifampicin-resistant TB (RR-TB). QT or QTcF prolongation ≥500 ms occurred in 31 (11%) of 282 Short regimen participants. The frequent ECG monitoring employed might be challenging for treatment programmes. This analysis aimed to determine whether those at higher risk of severe QT prolongation could be identified early for more targeted monitoring.METHODS: Data from the first month of treatment were used to investigate whether participants were at risk of developing QT/QTcF ≥500 ms. QTcF increases from baseline at different time points were examined. Absolute QTcF measurements were categorised in 5 ms increments at each time-point. The most discriminating time points and QTcF cut-offs were combined to optimise sensitivity and specificity.RESULTS: Absolute QTcF values were more discriminating than magnitude of increase from baseline. More participants who developed QT/QTcF ≥500 ms had a QTcF of respectively ≥425 ms and ≥430 ms at 4 h and Week 3 (P < 0.05) than those who did not. By combining QTcF values ≥425 ms at 4 h and ≥430 ms at Week 3, we identified high-risk participants with 97% sensitivity and 99% negative predictive value.CONCLUSION: Reduced ECG monitoring may be possible for many Short regimen participants.

Type: Article
Title: ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?
Location: France
Open access status: An open access version is available from UCL Discovery
DOI: 10.5588/ijtld.22.0063
Publisher version: https://doi.org/10.5588/ijtld.22.0063
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Antitubercular Agents, Electrocardiography, Humans, Long QT Syndrome, Randomized Controlled Trials as Topic, Rifampin
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10160227
Downloads since deposit
42Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item